SHORT-TERM OUTCOMES FOLLOWING LAPAROSCOPIC GASTRECTOMY FOR ADVANCED GASTRIC CANCER AT CAN THO CENTRAL GENERAL HOSPITAL AND CAN THO UNIVERSITY OF MEDICINE AND PHARMACY HOSPITAL
Main Article Content
Abstract
Background: Gastric cancer is one of the most common cancers in the world. In Viet Nam, gastric cancer is the fourth most common cancer in both genders, with almost all patients hospitalized and diagnosed at advanced and metastatic stages. Laparoscopic gastrectomy is currently considered to be one of the radical treatments. Objectives: To evaluate the outcomes following laparoscopic gastrectomy for advanced gastric cancer and without distant metastasis. Materials and methods: A cross-sectional descriptive study on 37 cases of advanced gastric cancer patients without distant metastases who underwent laparoscopic gastrectomy at Can Tho Central General Hospital and Can Tho University of Medicine and Pharmacy Hospital from January 2019 to May 2021. These patients were followed up after surgery until the end of the study. Results: The average age was 58.4, and the male/female ratio was 4/1. Thirty-one patients underwent laparoscopic distal gastrectomy, and six patients underwent totally laparoscopic gastrectomy. The mean operation time was 286.8 min, with a mean blood loss of 54.5 mL. The mean number of retrieved lymph nodes was 11.8 nodes. The mean proximal resection margins were 6.4 cm. The average length of post-operative was 8.4 days. There were two wound infections. After three months of surgery, the result: Good 75.7%, Moderate 16.2%, and Bad 8.1%. At six months and 12 months after surgery, survival rates were 97.1% and 90.6%, respectively. The median follow-up period was 15.8 months. Conclusion: Laparoscopic gastrectomy for advanced gastric cancer is a safe procedure.
Keywords
Gastric cancer, laparoscopic surgery
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
2. Võ Duy Long, (2017), Đánh giá kết quả phẫu thuật nội soi điều trị ung thư dày theo giai đoạn I,II,III, Luận án Tiến sĩ, Đại Học Y Dược Thành Phố Hồ Chí Minh, tr. 53-76.
3. Phạm Văn Nam, (2019), Nghiên cứu ứng dụng phẫu thuật nội soi cắt dạ dày, vét hạch D2, D2 mở rộng điều trị ung thư biểu mô dạ dày Luận án Tiến Sĩ, Đại Học Y Hà Nội, pp. 66-90.
4. Phạm Văn Năng, Phạm Văn Lình, (2014), Bệnh Học Ngoại Khoa Tiêu Hóa- Gan Mật, Nhà xuất bản Y học, tr. 41-49.
5. Hồ Chí Thanh, (2016), Nghiên cứu ứng dụng phẫu thuật nội soi hỗ trợ điều trị triệt căn ung thư biểu mô 1/3 dưới dạ dày tại Bệnh viện Quân y 103, Luận Án Tiến Sĩ, Học viện Quân Y, tr. 33- 65.
6. Phan Minh Trí, Đỗ Đình Công, (2021), Bệnh học Ngoại Khoa Tiêu Hóa, Nhà Xuất Bản Y Học, tr. 177-193.
7. Abdelhamed M A, Abdellatif A, Touny A, Mahmoud A M, et al, (2020), "Laparoscopic gastrectomy with D2 lymphadenectomy for gastric cancer: initial Egyptian experience at the National Cancer Institute", J Egypt Natl Canc Inst, 32 (1), pp. 10.
8. Chen K, Mou Y P, Xu X W, Cai J Q, et al, (2014), "Short-term surgical and long-term survival outcomes after laparoscopic distal gastrectomy with D2 lymphadenectomy for gastric cancer", BMC Gastroenterol, 14 pp. 41.
9. Courtney M. Townsend, (2021), Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice, Elsevier Health Sciences, pp. 1196-1239.
10. Japanese Gastric Cancer Association, (2021), "Japanese gastric cancer treatment guidelines 2018 (5th edition)", Gastric Cancer, 24 (1), pp. 1-21.
11. Lee H J, Hyung W J, Yang H K, Han S U, et al, (2019), "Short-term Outcomes of a Multicenter Randomized Controlled Trial Comparing Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy to Open Distal Gastrectomy for Locally Advanced Gastric Cancer (KLASS-02-RCT)", Ann Surg, 270 (6), pp. 983-991.
12. Organization W H, (2020), World cancer report 2020, International Agency for Research on Cancer, pp. 1-5.
13. Yamagata Y, Yoshikawa T, (2019), "Current status of the "enhanced recovery after surgery" program in gastric cancer surgery", 3 (3), pp. 231-238.